Clinical trials for advancing innovative interventions for neurodegenerative diseases

Ufuk Avrupa (Horizon Europe) · çağrı konusu HORIZON-HLTH-2027-02-DISEASE-14-two-stage (Cluster 1 - Health (Two stage - 2027)). Eylem türü: HORIZON Research and Innovation Actions.

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

• The scientific and clinical communities make effective use of state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to underpin and complement the development of innovative interventions aimed at more effective treatments for neurodegenerative diseases.
• The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond. …

Kaynak: Avrupa Komisyonu Funding & Tenders Portal (otomatik aktarım; ayrıntı ve güncel koşullar için resmî sayfaya bakın).

"> General conditions

• Admissibility Conditions, proposal page limit and layout

Applicants submitting a proposal for a blind evaluation (see General Annex F) must not disclose their organisation names, acronyms, logos nor names of personnel in the proposal abstract and Part B of their first-stage application (see General Annex E).

Admissibility conditions are  described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. …

Uygunluk: ülkenizin bu programa katılım durumunu ve ortaklık şartlarını resmî konu sayfasından teyit edin.